iVigee published the Expert Series asking CRO vs. Specialist Pharmacovigilance Provider: Which Should You Actually Choose?
Public source
Publisher name
Public post
Two regulatory updates to watch this week if you file in China or market in the Netherlands. 🇨🇳 China: The Center for Drug Evaluation has opened a public consultation…
Company
iVigee
- Industry
- Biotechnology Research
- Location
- Burlington, US
- Company size
- 51–200 employees
About iVigee
iVigee delivers physician-led pharmacovigilance grounded in truth. You receive pharmacovigilance services and consulting across the entire product lifecycle, from clinical development through post-marketing authorization. Our approach is built on transparency, regulatory realism, and straight answers you can trust, so you’re never left guessing. You work with physicians, former regulators, EU QPPVs, and senior safety leaders who understand how pharmacovigilance is evaluated in real inspections. We focus on what regulators actually look for, what they question, and what they expect you to explain, not just what guidance says. We support you as you build, optimize, and transform your pharmacovigilance capabilities, providing clarity at every stage, from early system design through mature, inspection-ready operations. Across everything we do, you always know where you stand, before inspections, before submissions, and before issues become findings. iVigee operates under an ISO 9001: 2015 – certified quality management system, ensuring the way we work is as structured, consistent, and accountable as the systems we help you establish and maintain.
See moreLatest activity
Latest activity from iVigee
13 signals
Presence & Recognition
iVigee hosted a conversation between Henry Seto and Jan Petracek discussing how AI is changing pharmacovigilance work and supervising it.
Presence & Recognition
iVigee hosted a conversation with Henry Seto discussing AI taking over daily pharmacovigilance work and supervising it.
Research & Knowledge
iVigee published the Netherlands policy on risk minimization measures
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
PrimeVigilance
PrimeVigilance published an article exploring how the role of medical monitors is evolving, with real-time data, risk-based approaches, and new technologies reshaping clinical trial oversight.
Research & Knowledge
International Society of Pharmacovigilance (ISoP)
International Society of Pharmacovigilance (ISoP) published the Abstract Book for the 25th ISoP Global Meeting: Ecosystems of Trust: Pharmacovigilance for a Healthier World in Drug Safety.
Research & Knowledge
Velocity Clinical Research, Inc.
Velocity Clinical Research, Inc. published The Recap, an exclusive article by Nick Spittal, detailing the industry's habit of picking sites one at a time.
Research & Knowledge
3Biotech
3Biotech published a Drug Development Roadmap whitepaper including practical guidance and downloadable Gantt charts to help visualize the journey from discovery to first-in-human studies.
Research & Knowledge
DICE-CRO